Table 7.

Diagnostic efficacy of 2-AG to diagnose ARE or IRE and diagnostic efficacy of OEA to diagnose FRE in dogs.

2-AG pmol/ml	Sensitivity	95% CI	Specificity	95%CI	+LR	–LR
≥1.9	100.00	81.5–100.0	0.00	0.0–30.8	1.00
>3.1	100.00	81.5–100.0	50.00	18.7–81.3	2.00	0.00
>3.3	94.44	72.7–99.9	60.00	26.2–87.8	2.36	0.36
>3.8	94.44	72.7–99.9	70.00	34.8–93.3	3.15	0.18
>3.9	88.89	65.3–98.6	70.00	34.8–93.3	2.96	0.54
>4.2	88.89	65.3–98.6	80.00	44.4–97.5	4.44	0.49
>6.2	77.78	52.4–93.6	80.00	44.4–97.5	3.89	0.65
>6.4	77.78	54.4–93.6	90.00	55.5–99.7	7.78	0.51
>15.4	38.89	17.3–64.3	90.00	55.5–99.7	3.89	0.64
>22.2	38.89	17.3–64.3	100.00	69.2–100		0.56
>169.9	0.00	0.0–18.5	100.00	69.2–100		0.68
OEA pmol/ml	Sensitivity	95% CI	Specificity	95%CI	+LR	–LR
≥17.2	100.00	69.2–100.0	0.00	0.0–18.5	1.00
>26.2	100.00	69.2–100.0	27.78	9.7–53.5	1.38	0.00
>32.8	90.00	55.5–99.7	27.78	9.7–53.5	1.25	0.36
>53.5	90.00	55.5–99.7	55.56	30.8–78.5	2.03	0.18
>65.3	70.00	34.8–93.3	55.56	30.8–78.5	1.57	0.54
>67	70.00	34.8–93.3	61.11	35.7–82.7	1.80	0.49
>67.5	60.00	26.2–87.8	61.11	35.7–82.7	1.54	0.65
>76.7	60.00	26.2–87.8	77.78	52.4–93.6	2.70	0.51
>84.4	50.00	18.7–81.3	77.78	52.4–93.6	2.25	0.64
>90.7	50.00	18.7–81.3	88.89	65.3–98.6	4.50	0.56
>101.6	40.00	12.2–73.8	88.89	65.3–98.6	3.60	0.68

2-AG, 2-arachidonoylglycerol; OEA, N-oleoylethanolamine; CI, confidence interval; LR, likelihood ratio.